Changes in the gut may be a risk factor for Parkinson’s disease
The takeawayBacteria in the gut plays a role in regulating movement disorders, such as Parkinson’s, in mice. Certain changes to the bacterial makeup of the gut may be a risk factor for developing the disease, supporting the idea that Parkinson’s may start in the gut, rather than the brain.
Why is it important?Several studies in recent years have shown that there is a link between the gut and Parkinson’s. In fact, many people who go on to be diagnosed with the disease report problems with constipation years before the onset of motor symptoms. A better understanding of this link gives scientists new insight into how the disease begins and opens new avenues for investigating ways to slow its progress.
- Novelty 100% 100%
- Proximity 60% 60%
- Deliverability 80% 80%
Impact“This study presents additional evidence linking the GI tract and Parkinson’s disease and begs the question—is it possible that the bacteria that we normally have in our gut may be altered in PD and trigger the initial steps in the disease process?“ Dr. Patrik Brundin
The detailsAlthough scientists have known for a while that the bacteria in the gut—collectively known as microbiota—can affect normal processes in the brain and nervous system, it was not clear how they influenced the development of diseases such as Parkinson’s. This study addresses that issue and, using microbiota samples from people with Parkinson’s (obtained from feces) and transplanting them into mice, found that gut microbiota can promote inflammation, influence the activation of certain brain cells as well as the onset of motor problems, and the spread of alpha-synuclein, a protein that makes up Lewy bodies found the brains of people with Parkinson’s.
Further to this, the addition of microbiota from Parkinson’s donors in mice with existing excess alpha synuclein enhanced physical impairments compared to microbiota transplants from healthy donors. These findings suggest that gut bacteria can regulate movement disorders in mice and alterations in the human microbiome represent a risk factor for Parkinson’s.